Advanced search
Showing results 8821 to 8830 on 8830 in total
-
Data Monitoring Committees and clinical trials: from scientific justification to organisation
Clara Locher, Silvy Laporte, Peggy Derambure, Olivier Chassany, Cécile Girault, Alix Avakiantz, Claire Bahans, Dominique Deplanque, Pierre Fustier, Anne Françoise Germe, Behrouz Kassai Koupai, Louis Lacoste, Nadine Petitpain, Matthieu Roustit, Tabassome Simon, Cecile Train, Michel Cucherat
-
Genetic Variability, Population Differentiation, and Correlations for Thermal Tolerance Indices in the Minute Wasp, Trichogramma cacoeciae
Michela Ion Scot, Lucas Margris, Nadine Sellier, Sylvie Warot, Flavio Gatti, Fabio Siccardi, Patricia Gibert, Elodie Vercken, Nicolas Ris
-
Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality
Roubi Kilo, Silvy Laporte, Rama Arab, Sabine Mainbourg, Steeve Provencher, Guillaume Grenet, Laurent Bertoletti, Laurent Villeneuve, Michel Cucherat, Jean-Christophe Lega
-
Meta-regression of randomized control trials with antithrombotics: weak correlation between net clinical benefit and all cause-mortality
Roubi Kilo, Silvy Laporte, Rama Arab, Sabine Mainbourg, Steeve Provencher, Guillaume Grenet, Laurent Bertoletti, Laurent Villeneuve, Michel Cucherat, Jean-Christophe Lega
-
Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis
Q. Reynaud, Jean-Christophe Lega, P. Mismetti, C. Chapelle, D. Wahl, P. Cathebras, S. Laporte
-
Consistency of safety profile of new oral anticoagulants in patients with renal failure
Jean-Christophe Lega, L. Bertoletti, C. Gremillet, C. Boissier, P. Mismetti, S. Laporte
-
Consistency of Safety and Efficacy of New Oral Anticoagulants across Subgroups of Patients with Atrial Fibrillation
Jean-Christophe Lega, L. Bertoletti, C. Gremillet, C. Chapelle, P. Mismetti, M. Cucherat, D. Vital-Durand, S. Laporte, Behalf of The Meta-Embol Group
-
Impact of double-blind vs. open study design on the observed treatment effects of new oral anticoagulants in atrial fibrillation: a meta-analysis
Jc. Lega, P. Mismetti, M. Cucherat, T. Fassier, L. Bertoletti, C. Chapelle, S. Laporte
-
Exploring endogenous retroviruses in ruminant genomes: They might not be all dead after all
Marie Verneret, Caroline Leroux, Thomas Faraut, Vincent Navratil, Emmanuelle Lerat, Jocelyn Turpin
-
A revisited version of the disputatio for pharmacological training: An educational study
Louise Carton, Perle Totoson, Edouard-Jules Laforgue, Jean-Marc Pelerin, Thomas Portier-Feunteun, Sabine Mainbourg, Dominique Deplanque, Luc Zimmer, Silvy Laporte, Régis Bordet, Guillaume Grenet, Samuel Legeay